Novel Insights into Leukemogenesis

Description of the granted funding

We have very recently identified the first predisposing gene for a specific type of acute myeloid leukemia (AML). We have demonstrated that a homozygous mutation in ERCC6L2 gene causes AML with distinct characteristics. We have shown that individuals with the bi-allelic mutations develope AML with erythroid predominance and very poor prognosis. Hence, ERCC6L2 defines a novel entity within inherited acute myeloid leukemia. We will provide new insights into leukemogenesis and normal hematopoiesis focusing on the specific features of ERCC6L2 defect-driven leukemia. Furthermore, we will gain deeper understanding in normal hematopoiesis.
Show more

Starting year

2022

End year

2026

Granted funding

Outi Kilpivaara Orcid -palvelun logo
500 000 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Other information

Funding decision number

349760

Fields of science

Genetics, developmental biology, physiology

Research fields

Perinnöllisyystiede

Identified topics

cancer